“A U.S.-led sovereign wealth fund for preclinical and early stage biotechs ... I think it's an interesting idea, but ... the things that I described are probably more top of mind”

Simeon George · Business Of Biotech · AI, China, And Biotech Investing With SR One's Simeon George, M.D.

Play from 42:57
42:57

Audio streams from the publisher’s own feed. Verbatim does not host or copy it.

What was described

discussed the idea of a U.S. sovereign wealth fund to finance pre-clinical and early-stage biotech companies

Said nearby on the same subject

“We're currently investing out of our fifth fund and primarily spend all of our time, like I mentioned, early stage. So really everyone from having an idea up until series A companies”
♫
Said on The Jason & Scot Show - E-Commerce And Retail News
Business model Share this moment
“…there is no way of consolidating public finances without restoring some form of a wealth tax… we will return to the wealth tax that we had in 2017”
♫
Said on Odd Lots
Contrarian take Share this moment
“We spent six months basically fundraising on Zoom... that year there was so much interest in what was happening in biotech... we took advantage of that window to be able to create that first fund. That first one was a 500 million vehicle”
SG
Simeon George / SR1 Capital Management
Business Of Biotech ·
Why it worked $500 million Share this moment
“The Australian Government financed and paid for pre-COP out of the reallocation of the $500 million on international climate discussions”
♫
Said on Australian Parliament: House of Representatives
Business model $500 million Share this moment

Moments like this, every Monday

The strongest new moments on your topics, in the speakers' own words. Free for three topics.

No card. No password. One-click unsubscribe.

Track a competitor?

Pro watches up to 25 names or phrases and emails you the morning after they are said.

See Pro, $29 a month

Verbatim quotes a short extract and links to the episode; the episode belongs to its publisher. Remove a show.